Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial.
- DOI
- 10.1111/bjh.70611
- Published
- 2026 Aug
- Container
- British journal of haematology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bjh.70611,
title = {Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial.},
author = {Hall A and Croft J and Walker K and Boyd K and Roberts S and Holroyd A and Garg M and Ferris E and Cook G and Pierceall WE and Thakurta A and Gandhi A and Pawlyn C and Brown SR and Kaiser M},
year = {2026},
journal = {British journal of haematology},
doi = {10.1111/bjh.70611},
url = {https://doi.org/10.1111/bjh.70611}
}RIS
TY - JOUR TI - Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial. AU - Hall A AU - Croft J AU - Walker K AU - Boyd K AU - Roberts S AU - Holroyd A AU - Garg M AU - Ferris E AU - Cook G AU - Pierceall WE AU - Thakurta A AU - Gandhi A AU - Pawlyn C AU - Brown SR AU - Kaiser M PY - 2026 JO - British journal of haematology DO - 10.1111/bjh.70611 UR - https://doi.org/10.1111/bjh.70611 ER -
APA
A, H., J, C., K, W., K, B., S, R., A, H., M, G., E, F., G, C., WE, P., A, T., A, G., C, P., SR, B., & M, K. (2026). Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial.. British journal of haematology. https://doi.org/10.1111/bjh.70611
Source records
- pubmed · retrieved 2026-09-26T00:25:39.264Z